PL370804A1 - Szczepionka przeciw Streptococcus pneumoniae - Google Patents

Szczepionka przeciw Streptococcus pneumoniae

Info

Publication number
PL370804A1
PL370804A1 PL02370804A PL37080402A PL370804A1 PL 370804 A1 PL370804 A1 PL 370804A1 PL 02370804 A PL02370804 A PL 02370804A PL 37080402 A PL37080402 A PL 37080402A PL 370804 A1 PL370804 A1 PL 370804A1
Authority
PL
Poland
Prior art keywords
streptococcus pneumoniae
pneumoniae vaccine
vaccine
streptococcus
pneumoniae
Prior art date
Application number
PL02370804A
Other languages
English (en)
Inventor
Craig Anthony Joseph Laferriere
Jan Poolman
Original Assignee
Glaxosmithkline Biologicals S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biologicals S.A. filed Critical Glaxosmithkline Biologicals S.A.
Publication of PL370804A1 publication Critical patent/PL370804A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL02370804A 2001-12-18 2002-12-18 Szczepionka przeciw Streptococcus pneumoniae PL370804A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0130215.7A GB0130215D0 (en) 2001-12-18 2001-12-18 Vaccine

Publications (1)

Publication Number Publication Date
PL370804A1 true PL370804A1 (pl) 2005-05-30

Family

ID=9927830

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02370804A PL370804A1 (pl) 2001-12-18 2002-12-18 Szczepionka przeciw Streptococcus pneumoniae

Country Status (19)

Country Link
US (1) US20050214329A1 (pl)
EP (1) EP1463519A2 (pl)
JP (1) JP2005516932A (pl)
KR (1) KR20040074091A (pl)
CN (1) CN1635904A (pl)
AU (1) AU2002361007A1 (pl)
BR (1) BR0215089A (pl)
CA (1) CA2470645A1 (pl)
CO (1) CO5590937A2 (pl)
GB (1) GB0130215D0 (pl)
HU (1) HUP0402471A3 (pl)
IL (1) IL162383A0 (pl)
IS (1) IS7297A (pl)
MX (1) MXPA04006073A (pl)
NO (1) NO20043018L (pl)
PL (1) PL370804A1 (pl)
RU (1) RU2004117775A (pl)
WO (1) WO2003051392A2 (pl)
ZA (1) ZA200404803B (pl)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763244B1 (fr) 1997-05-14 2003-08-01 Pasteur Merieux Serums Vacc Composition vaccinale multivalente a porteur mixte
AU2011253684B8 (en) * 2005-04-08 2013-07-11 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
US20070184072A1 (en) 2005-04-08 2007-08-09 Wyeth Multivalent pneumococcal polysaccharide-protein conjugate composition
EP3311836A1 (en) * 2005-04-08 2018-04-25 Wyeth LLC Multivalent pneumococcal polysaccharide-protein conjugate composition
US7709001B2 (en) 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
US7955605B2 (en) 2005-04-08 2011-06-07 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
KR101515078B1 (ko) * 2005-12-22 2015-04-24 글락소스미스클라인 바이오로지칼즈 에스.에이. 백신
AU2012216698B2 (en) * 2005-12-22 2014-03-06 Glaxosmithkline Biologicals Sa Pneumococcal polysaccharide conjugate vaccine
WO2007127668A2 (en) * 2006-04-26 2007-11-08 Wyeth Novel processes for coating container means which inhibit precipitation of polysaccharide-protein conjugate formulations
US8808707B1 (en) 2006-05-08 2014-08-19 Wyeth Llc Pneumococcal dosing regimen
WO2008022299A1 (en) * 2006-08-17 2008-02-21 The Uab Research Foundation Diagnosing pneumococcal pneumonia
CN1971275B (zh) * 2006-12-06 2012-07-04 云南沃森生物技术股份有限公司 肺炎链球菌6b型、18c型、19f型、23f型多糖结合物中游离多糖含量的测定方法
JP2010525035A (ja) * 2007-05-02 2010-07-22 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン
CA2690708A1 (en) * 2007-06-26 2008-12-31 Glaxosmithkline Biologicals S.A. Vaccine
US20160228500A9 (en) * 2007-07-23 2016-08-11 Martina Ochs Immunogenic Polypeptides and Monoclonal Antibodies
WO2009012588A1 (en) * 2007-07-23 2009-01-29 Sanofi Pasteur Limited Immunogenic polypeptides and monoclonal antibodies
GB201003924D0 (en) * 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
MX2013006255A (es) 2010-12-03 2015-08-05 Sanofi Pasteur Ltd Composicion para inmunizacion contra streptococcus pneumoniae.
MX354103B (es) * 2012-01-30 2018-02-13 Serum Inst India Ltd Composicion inmunogenica.
EA201590491A1 (ru) * 2012-10-17 2016-01-29 Глаксосмитклайн Байолоджикалс С.А. Иммуногенная композиция
US20140105927A1 (en) * 2012-10-17 2014-04-17 Glaxosmithkline Biologicals S.A. Immunogenic composition
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
CN106109486A (zh) * 2015-07-06 2016-11-16 北京科兴中维生物技术有限公司 一种组合物及其制备方法与应用
CA3052621A1 (en) 2017-02-03 2018-08-09 Schadeck, Eva Barbara Haemophilus influenzae saccharide-carrier conjugate compositions and uses thereof
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
US10729763B2 (en) 2017-06-10 2020-08-04 Inventprise, Llc Mixtures of polysaccharide-protein pegylated compounds
WO2018227177A1 (en) * 2017-06-10 2018-12-13 Inventprise, Llc Multivalent conjugate vaccines with bivalent or multivalent conjugate polysaccharides that provide improved immunogenicity and avidity
WO2019070994A1 (en) 2017-10-04 2019-04-11 Liffey Biotech Limited SACCHARIDE-POLYPEPTIDE CONJUGATE COMPOSITIONS AND METHODS OF USE
ES3058336T3 (es) 2017-12-06 2026-03-10 Merck Sharp & Dohme Llc Composiciones que comprenden conjugados polisacárido-proteína de Streptococcus pneumoniae y métodos de uso de los mismos
EP3749357A4 (en) 2018-02-05 2022-04-20 Sanofi Pasteur, Inc. POLYVALENT PNEUMOCOCCAL POLYSACCHARIDE PROTEIN CONJUGATE COMPOSITION
US11951162B2 (en) * 2018-04-18 2024-04-09 Sk Bioscience Co., Ltd. Streptococcus pneumoniae capsular polysaccharides and immunogenic conjugate thereof
WO2022035816A1 (en) 2020-08-10 2022-02-17 Inventprise, Llc Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24f
KR20220102871A (ko) * 2021-01-14 2022-07-21 (주)셀트리온 다가 폐렴구균 다당류-단백질 접합체를 포함하는 면역원성 조성물
CN118702827B (zh) 2024-08-27 2025-03-07 南京澄实生物医药科技有限公司 一种预防肺炎链球菌感染的融合蛋白及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811102A (en) * 1995-06-07 1998-09-22 National Research Council Of Canada Modified meningococcal polysaccharide conjugate vaccines
FR2763244B1 (fr) * 1997-05-14 2003-08-01 Pasteur Merieux Serums Vacc Composition vaccinale multivalente a porteur mixte
ATE459373T1 (de) * 1999-03-19 2010-03-15 Glaxosmithkline Biolog Sa Impfstoff gegen kapsulare polysaccharide von streptococcus pneumoniae

Also Published As

Publication number Publication date
WO2003051392A2 (en) 2003-06-26
MXPA04006073A (es) 2005-03-31
WO2003051392A3 (en) 2003-11-13
ZA200404803B (en) 2005-08-29
RU2004117775A (ru) 2005-04-20
HUP0402471A3 (en) 2005-04-28
IL162383A0 (en) 2005-11-20
US20050214329A1 (en) 2005-09-29
IS7297A (is) 2004-06-03
HUP0402471A2 (hu) 2005-03-29
CO5590937A2 (es) 2005-12-30
GB0130215D0 (en) 2002-02-06
CA2470645A1 (en) 2003-06-26
EP1463519A2 (en) 2004-10-06
KR20040074091A (ko) 2004-08-21
NO20043018L (no) 2004-07-15
JP2005516932A (ja) 2005-06-09
BR0215089A (pt) 2004-11-16
CN1635904A (zh) 2005-07-06
AU2002361007A1 (en) 2003-06-30

Similar Documents

Publication Publication Date Title
IL162383A0 (en) Streptococcus pneumoniae vaccine
GB0107658D0 (en) Streptococcus pneumoniae
SI1162999T1 (sl) Vakcina proti Streptococcus pneumoniae
AU2002351623A8 (en) Streptococcus antigens
HUP0301656A3 (en) Streptococcus antigens
AU2003299535A8 (en) Group b streptococcus vaccine
IL164242A0 (en) Protein-based streptococcus pneumoniae vaccines
HUP0402259A3 (en) Vaccines
GB0407935D0 (en) Vaccine
GB0306611D0 (en) Novel vaccine
IL157498A0 (en) Vaccine
GB0121171D0 (en) Vaccine
GB9928678D0 (en) Streptococcus pneumoniae antigens
AU7193501A (en) Multiple antigenic peptides immunogenic against streptococcus pneumoniae
GB0105238D0 (en) Vaccines
GB2370770B (en) Uses of Streptococcus Vaccines
HK1057697A (en) Vaccine against streptococcus pneumoniae
GB0026333D0 (en) Streptococcus antigens
GB0028727D0 (en) Streptococcus antigens
GB0105640D0 (en) Streptococcus proteins
GB0130823D0 (en) Vaccine
GB0106589D0 (en) Vaccine
GB0103867D0 (en) Vaccine
GB0128312D0 (en) Vaccine
GB0124137D0 (en) Vaccine

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)